SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-003610
Filing Date
2018-01-23
Accepted
2018-01-23 17:00:59
Documents
1
Period of Report
2018-01-19

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3828
  Complete submission text file 0001104659-18-003610.txt   5416
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IASO PHARMA INC. 12707 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
Gemignani Gary G (Reporting) CIK: 0001512256 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35268 | Film No.: 18543003